Promoter library and application thereof in different bacteria
By saturating the promoter sequence and generating a promoter library of consistency strength, the problem of inconsistent application between different bacteria is solved, and efficient gene expression regulation and engineering construction in E. coli and Roche eutrophic bacteria is achieved, which has improved the Application potential of industrial microorganisms.
Patent Information
- Application Number
- PCT/CN2023/108339
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-11
- Filing Date
- 2023-07-20
- Publication Date
- 2024-11-14
AI Technical Summary
The existing biological elements, especially promoter libraries, have inconsistent applications among different bacteria, resulting in difficulties in regulating and engineering gene expression in potential industrial strains such as Rochefacteria, which limits their industrial applications.
By performing saturation mutations on the original promoter sequence, a promoter library with a wide range of promoter strength and consistency among different bacteria, including 64 different promoter sequences, ensuring that bacteria such as E. coli and Rochetia are included in bacteria. All functions can be effectively performed.
Achieves the consistency of the dynamic range of promoter strength up to 103 times, and its transplantability among different bacteria provides important biological elements for gene expression regulation and engineering bacterial construction, improving the production efficiency and application potential of industrial microorganisms. .
Smart Images

Figure CN2023108339_14112024_PF_FP_ABST
Abstract
Description
A promoter library and its application in different bacteria Technical Field
[0001] The present invention relates to the technical field of genetic engineering, in particular to a promoter library and applications thereof in different bacteria. Background Art
[0002] Synthetic biology, grounded in systems design and engineering concepts, aims to reduce the complexity of studying natural biological systems or reconstruct complex artificial biological systems through the principles of engineering science. In practice, this can be achieved through the precise regulation of biological components to control biosynthetic pathways for optimal production of target products. Alternatively, biological systems with desired functions can be constructed by connecting different biological components in series, feedback, or feedforward configurations. Biological components are the core and most important foundation of synthetic biology systems.
[0003] Promoters are biological elements that determine the start site of transcription and control the intensity of gene expression. They are a core component of gene expression systems. Controlling gene activity through promoter strength is a common biological regulatory method. Therefore, a promoter library containing a range of promoters of varying strengths is needed to meet varying gene expression requirements.
[0004] Industrial microorganisms are microorganisms derived from nature that can be used directly (or after modification) in production. Bacteria successfully used in industrial production include Escherichia coli, Corynebacterium glutamicum, and Streptomyces. Other bacteria considered potential industrial strains include Pseudomonas aeruginosa, Eutropha rosea, and Clostridium autoethanogenum. Fine-tuning genes through promoters can optimize the synthetic pathways of industrial microorganisms, thereby increasing yield and conversion rates and reducing production costs.
[0005] As a model organism for microbial research, Escherichia coli has a well-defined genetic background, and the development of related genetic elements, such as promoters, is relatively mature. However, biological elements (such as promoter libraries) constructed in one bacterium may not be applicable to other bacteria, which to some extent restricts the expansion and application of biological elements.
[0006] Ralstonia eutropha (now renamed Cupriavidus necator) is a Gram-negative bacterium that can utilize a variety of carbon sources, such as sugars and lipids, as substrates. It serves as a model strain for PHA production and has great potential for industrial production. Currently, basic research on Ralstonia eutropha is in its early stages. While some biocomponents have been reported for use in Ralstonia eutropha, most of these involve migrating biocomponents from Escherichia coli to new substrates. This process often results in mismatches between the component test results and the original substrate. This scarcity of biocomponents directly hinders the development and application of Ralstonia eutropha as an industrial microorganism. Therefore, developing biocomponents that can be stably transferred between different bacteria is crucial.
[0007] Summary of the Invention
[0008] The invention provides a promoter library and application thereof in different bacteria.
[0009] The present invention is based on an original promoter sequence, and performs saturation mutation on the bases in the promoter sequence (changing n bases can produce 4 n By changing the promoter strength by using a variety of mutations (e.g., serotypes), a promoter library with a wide range of promoter strengths and high strength consistency among different bacteria was obtained.
[0010] Specifically, the present invention provides the following technical solutions:
[0011] The present invention provides a promoter library, which includes a promoter with a nucleotide sequence as shown in SEQ ID NO.1, wherein n represents any one of a, t, c, and g.
[0012] The promoter sequence in the above promoter library is as follows (SEQ ID NO.1, 5'-3'):
[0013] (where n represents any one of a, t, c, and g).
[0014] The above promoter sequence specifically includes the following parts: an upstream sequence (upstream of the underlined sequence), a core region (the underlined sequence, with the -10 region and -35 region marked in bold), and a downstream sequence (spacer, downstream of the underlined sequence). The core region is the part that performs the "on / off" function of the promoter, the upstream sequence (upper element) can affect the strength of the promoter by interacting with bacterial RNA polymerase, and the downstream sequence is the spacer sequence between the promoter and other sequences.
[0015] In the above promoter sequence, n can be any one of a, t, c, and g, so the above promoter sequence includes a total of 64 different promoter sequences.
[0016] In some embodiments of the present invention, the promoter library comprises 1-64 promoters.
[0017] In some embodiments of the present invention, the promoter library comprises 2-64 promoters.
[0018] In some embodiments of the present invention, the promoter library includes 64 promoters.
[0019] In some embodiments of the present invention, the promoter library includes promoters with nucleotide sequences as shown in SEQ ID NO. 2-41.
[0020] It has been verified that the dynamic range of the promoter strength in the promoter library mentioned above is 10 3 The promoter library has high portability among different bacteria.
[0021] The present invention provides a promoter, which is the promoter in the promoter library described above.
[0022] In some embodiments of the present invention, the promoter provided above is any one of the promoters in the promoter library.
[0023] The present invention provides an expression cassette, which comprises the promoter in the above-mentioned promoter library.
[0024] Preferably, the expression cassette comprises at least one promoter from the promoter library described above.
[0025] In the present invention, the expression cassette refers to a recombinant nucleic acid molecule obtained by connecting a promoter to a target gene.
[0026] The present invention provides a vector, which comprises the promoter in the above-mentioned promoter library or the above-mentioned expression cassette.
[0027] Preferably, the vector comprises at least one promoter from the promoter library described above.
[0028] The vector of the present invention can be a plasmid vector or a viral vector, preferably an expression vector.
[0029] The present invention provides a host cell, which comprises the promoter in the promoter library described above, or the expression cassette described above, or the vector described above.
[0030] Preferably, the host cell comprises at least one promoter from the promoter library described above.
[0031] In the host cell, the promoter may be integrated into the chromosome of the host cell, or exist on a plasmid vector carried by the host cell.
[0032] The host cells described above include microbial cells. The microorganisms include, but are not limited to, Escherichia (e.g., Escherichia coli), Cupribotium (e.g., Eutropha rothiae), Corynebacterium (e.g., Corynebacterium glutamicum), Brevibacterium, Arthrobacter, Microbacterium, Bacillus, Pseudomonas, Streptomyces, etc.
[0033] In some embodiments of the present invention, the host cell is Escherichia coli.
[0034] In some embodiments of the present invention, the host cell is Eutropha rosea.
[0035] The present invention provides a recombinant engineered bacterium, which comprises the promoter in the promoter library described above.
[0036] Preferably, the recombinant engineered bacteria comprises at least one promoter in the promoter library described above.
[0037] The present invention provides any one of the following applications of the above-mentioned promoter library, the promoter, the expression cassette, the vector, or the host cell:
[0038] (1) Application in regulating gene transcription and / or expression in microorganisms;
[0039] (2) Application in microbial gene editing;
[0040] (3) Application in genetic engineering of microorganisms;
[0041] (4) Application in the construction of engineered microorganisms for producing target products;
[0042] (5) Application in the production of target products using microbial fermentation.
[0043] In (1) and (2) above, the gene includes a nucleic acid molecule capable of encoding a peptide or functional RNA. The present invention does not specifically limit the type and sequence of the gene, and the gene may be any target gene that is desired to be transcribed and expressed.
[0044] In the above (4) and (5), the target product includes compounds, polymers or proteins, including but not limited to polyesters (such as polyhydroxyalkanoates), polyphenol compounds, amino acids or their derivatives, organic acids or their derivatives, etc.
[0045] In the above (1)-(5), the microorganisms include but are not limited to Escherichia (e.g., Escherichia coli), Cupribotium (e.g., Eutropha roxburghii), Corynebacterium (e.g., Corynebacterium glutamicum), Brevibacterium, Arthrobacter, Microbacterium, Bacillus, Streptomyces, Pseudomonas, etc.
[0046] Preferably, the microorganism is Escherichia coli or Eutropha rosea.
[0047] The present invention provides a method for regulating gene transcription and / or expression, which comprises the step of operably linking a promoter in the above-mentioned promoter library to a target gene.
[0048] The above method for regulating gene transcription and / or expression further comprises the step of introducing the ligation product of the promoter in the above promoter library and the target gene into a host cell.
[0049] The present invention provides an expression system comprising the promoter in the promoter library described above.
[0050] The present invention provides a method for constructing a promoter library with different expression strengths in microorganisms, which comprises the steps of transferring the above-mentioned expression system containing the promoters in the promoter library into different bacteria.
[0051] Wherein, the microorganisms include Escherichia (such as Escherichia coli) and Cupriavidus (such as Eutropha rosea).
[0052] In some embodiments of the present invention, an expression system of the above promoter library is constructed by DNA assembly technology, and the expression system is transformed into different bacteria to quantitatively test the strength of the promoter.
[0053] The beneficial effects of the present invention are that the promoter library of the present invention can cover a wide range of strengths and can function in different bacteria (for example, Escherichia coli and Eutropha rosea); and the strength of the same promoter in different bacteria is highly consistent and portable between different bacteria. It can be used to construct expression systems with different expression strengths in different bacteria, providing important biological elements for gene expression regulation in different bacteria and the construction of engineered bacteria. BRIEF DESCRIPTION OF THE DRAWINGS
[0054] In order to more clearly illustrate the technical solutions in the present invention or the prior art, a brief introduction is given below to the drawings required for use in the embodiments or the description of the prior art. Obviously, the drawings described below are some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying any creative work.
[0055] FIG1 is a schematic diagram showing the principles of construction and testing of an expression system containing a promoter library of the present invention.
[0056] FIG2 is a plasmid map in Example 1 of the present invention.
[0057] FIG3 shows the expression intensity of the promoter library in Example 1 of the present invention in Escherichia coli.
[0058] FIG4 shows the expression intensity of the promoter library in Example 2 of the present invention in Eutropha rosea.
[0059] FIG5 shows the correlation of expression intensities of the promoter library in Example 2 of the present invention in Escherichia coli and Eutropha rosea. DETAILED DESCRIPTION
[0060] To make the objectives, technical solutions, and advantages of the present invention more clear, the technical solutions of the present invention will be clearly and completely described below in conjunction with the accompanying drawings. Obviously, the embodiments described are only some of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without making creative efforts shall fall within the scope of protection of the present invention.
[0061] In the following examples, the enzyme reagents used were purchased from ThermoFisher and New England Biolabs (NEB), the kit used for plasmid extraction was purchased from Tiangen Biochemical Technology (Beijing) Co., Ltd., and the kit for recovering DNA fragments was purchased from Omega Corporation in the United States. The corresponding operating steps were carried out strictly in accordance with the product instructions. All culture media were prepared with deionized water unless otherwise specified.
[0062] The culture medium formula used in the following examples is as follows:
[0063] 1. Escherichia coli culture medium
[0064] LB medium: 5 g / L yeast extract, 10 g / L peptone, 10 g / L sodium chloride, the remainder water. Sterilize with high-temperature, high-pressure steam (121°C, 20 min).
[0065] 2. Roche Eutropha Culture Medium
[0066] TYGA medium: 5 g / L yeast extract, 10 g / L peptone, 3 g / L glucose, 3 g / L ammonium sulfate, the remainder water. Sterilize with high-temperature, high-pressure steam (121°C, 20 min).
[0067] During the actual culture process, a certain concentration of antibiotics may be added to the above culture medium to maintain the stability of the plasmid, such as 100 μg / mL ampicillin or 20 μg / mL tetracycline.
[0068] In the following examples, a schematic diagram of the principle of an expression system containing a promoter library is shown in Figure 1. The promoter regulates the expression of green fluorescent protein, and the fluorescence intensity is detected by flow cytometry, and the fluorescence intensity value is used to quantitatively characterize the strength of the promoter.
[0069] Example 1 Construction and testing of an expression system containing a promoter library in Escherichia coli
[0070] The pBBR1 plasmid containing the original promoter sequence (numbered 0), the sfGFP gene and other test sequences was synthesized by WuXi AppTec (see Figure 2 for the plasmid structure). Using this plasmid as a template, two fragments were obtained by PCR amplification. The primers and amplification product information are shown in Table 1.
[0071] Table 1
[0072] Among them, lib-P1-F is a degenerate primer (n represents any of a, t, c, or g). This design introduces a three-base saturation mutation in the promoter-10 region to construct a promoter library. After purification, the two fragments obtained by PCR were ligated using Gibson Assembly to generate pBBR1-promoter_lib1. The plasmid was transformed into Escherichia coli to generate a promoter library. The promoter sequence in the promoter library is as follows (SEQ ID NO. 1):
[0073] (where n represents any one of a, t, c, and g).
[0074] Each positive single clone in the transformed E. coli contained a promoter whose sequence corresponded to SEQ ID NO. 1. Positive clones were randomly selected from the promoter library and sequenced to determine their sequences. A total of 40 different promoter sequences were obtained (Table 2).
[0075] Table 2
[0076] After the above-mentioned E. coli positive clones containing different promoters were activated and cultured in LB medium, the fluorescence intensity was detected by flow cytometry, and the dynamic range of the fluorescence intensity was 10 3 The results are shown in Figure 3. The fluorescence intensity values of Escherichia coli containing the above promoter sequence are shown in Table 3.
[0077] Table 3
[0078] Example 2 Construction and testing of an expression system containing a promoter library in Eutropha rosea
[0079] The plasmid of the promoter library constructed in Example 1 was transformed into E. coli by conjugation to obtain an expression system containing the promoter library. E. coli containing different promoters was activated and cultured in TYGA medium and then the fluorescence intensity was detected by flow cytometry. The dynamic range of the fluorescence intensity was 10 3 The results are shown in Figure 4. The fluorescence intensity values of Eutropha rhodii containing the above promoter sequence are shown in Table 4.
[0080] Table 4
[0081] The expression intensity of the same promoter in the promoter library in Escherichia coli is used as the horizontal axis and the expression intensity in Eutropha rothrips is used as the vertical axis to make a scatter plot, and a fitting curve is made for all the points to determine the coefficient R 2 The expression intensity of the promoter library of the present invention was 0.9183, as shown in Figure 5. The results show that the promoter library of the present invention has good expression intensity consistency between Escherichia coli and E. rhodesii.
[0082] It should be noted that: the application, after obtaining positive clones, has taken the mode of random selection to carry out sequencing, and can be considered as the random sampling verification of all 64 kinds of promoters in the promoter library. According to the above-described embodiment, no matter in intestinal bacteria or in eutropha rosenbergii, 40 promoters randomly selected in the application's promoter library can all play promoter function in intestinal bacteria and eutropha rosenbergii, and all have good expression intensity consistency between intestinal bacteria and eutropha rosenbergii. In addition, it is known that the promoter sequences of 40 positive clones randomly selected by the application are at three base n places, a, t, c, g four kinds of bases are evenly distributed, distribution frequency has no significant difference, and there is no situation that a certain base is highly concentrated and selected, and there is also no close correlation or linkage between the bases in different positions. Combined with the role and influence of the promoter sequence on the binding of RNA polymerase to template DNA, those skilled in the art can reasonably expect that the promoter sequences other than the 40 sequences verified in the specification of the present application can achieve the effect of enhancing downstream gene expression, can play a promoter function in Escherichia coli and Eutropha rosea, and show good consistency of expression intensity between Escherichia coli and Eutropha rosea.
[0083] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or make equivalent replacements for some of the technical features therein. However, these modifications or replacements do not deviate the essence of the corresponding technical solutions from the spirit and scope of the technical solutions of the various embodiments of the present invention. Industrial Applicability
[0084] The promoter library of the present invention can cover a wide range of strengths and can function in different bacteria. In addition, the strength of the same promoter in different bacteria is highly consistent and portable between different bacteria. It can be used to construct expression systems with different expression strengths in different bacteria, providing important biological elements for gene expression regulation in different bacteria and the construction of engineered bacteria, and has good industrial application prospects.
Claims
1. A promoter library, characterized in that: The promoter library includes a promoter with a nucleotide sequence as shown in SEQ ID NO.1, wherein n represents any one of a, t, c, and g.
2. The promoter library according to claim 1, characterized in that The promoter library includes promoters whose nucleotide sequences are shown as SEQ ID NO. 2-41.
3. A promoter, characterized in that The promoter is a promoter in the promoter library according to claim 1 or 2.
4. An expression cassette, characterized in that The expression cassette comprises a promoter in the promoter library of claim 1 or 2.
5. A carrier, characterized in that The vector comprises a promoter in the promoter library of claim 1 or 2, or comprises the expression cassette of claim 4.
6. A host cell, characterized in that The host cell comprises a promoter in the promoter library of claim 1 or 2, or comprises the expression cassette of claim 4, or comprises the vector of claim 5.
7. The host cell according to claim 6, characterized in that The host cell is a microbial cell, and the microorganism includes microorganisms of the genera Escherichia, Cupriavidus, Corynebacterium, Brevibacterium, Arthrobacter, Microbacterium, Bacillus, Pseudomonas, and Streptomyces.
8. A recombinant engineered bacterium, characterized in that: The recombinant engineered bacteria comprises the promoter in the promoter library according to claim 1 or 2.
9. Any one of the following uses of the promoter library of claim 1 or 2, the promoter of claim 3, the expression cassette of claim 4, the vector of claim 5, or the host cell of claim 6 or 7: (1) Application in regulating gene transcription and / or expression in microorganisms; (2) Application in microbial gene editing; (3) Application in genetic engineering of microorganisms; (4) Application in the construction of engineered microorganisms for producing target products; (5) Application in the production of target products using microbial fermentation.
10. A method for regulating gene transcription and / or expression, characterized in that: The method comprises the step of operably linking a promoter in the promoter library of claim 1 or 2 to a target gene.
Citation Information
Patent Citations
Promoter library and method for constructing expression system with different strengths in bacteria by using same
CN108977890A
Corynebacterium glutamicum artificial promoter library
CN110317807A
Combination therapies of microorganisms and immune modulators for use in treating cancer
CN113286615A
Promoter library as well as preparation method and application thereof
CN114686990A
Tac promoter mutant library and application thereof
CN115961356A
